Nurse Practitioner, Gerontology · Saint Louis, MO
NPI
1598163016
Since 2014
Specialty
Nurse Practitioner, Gerontology
Code 363LG0600X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1 Barnes Jewish Hospital Plz, Div Im Infectious Disease
Saint Louis, MO, 63110
Phone (314) 747-1206
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,782
85 services
Medicare patients, 2024
40
Average age 64
Drug cost, 2024
$127K
37 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carrie L Brandstetter was code 99233 (hospital e&m - subsequent), 56 times for 31 patients. In total Carrie L Brandstetter billed 85 services in 3 codes, and Medicare paid $5,782.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 56 | 31 | $77.06 | $4,316 |
| 99232 Hospital E&M - Subsequent | Facility | 28 | 14 | $51.20 | $1,434 |
By year: 2022 $698 for 19 services; 2023 $2,872 for 49 services; 2024 $5,782 for 85 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carrie L Brandstetter prescribed most often to Medicare patients was Zerbaxa (Ceftolozane/Tazobactam), with 17 prescriptions and refills. In total Carrie L Brandstetter wrote 37 Medicare prescriptions that cost $127K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Zerbaxa Ceftolozane/Tazobactam | 17 | 17 | Under 11 | $98K |
Brand drugs: 20 claims; generic drugs: 17 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Carrie L Brandstetter were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.